Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide. 1980

E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox

The cause of hyperphosphatemia in patients with tumoral calcinosis never been explained. We studied two related patients who had tumoral calcinosis and hyperphosphatemia and two normal controls to determine their renal tubular response to parathyroid hormone (PTH) and acetazolamide (ACZ). During baseline periods, the patients had abnormally low fractional excretion of phosphorus (FEP) despite their hyperphosphatemia. Values for patients were 0.114 and 0.128; for controls, values were 0.193 and 0.165. PTH caused an increase in FEP and urinary cAMP in both patients and controls. ACZ also increased FEP in both groups, and the effects of PTH and ACZ were additive, suggesting that patients with tumoral calcinosis have normal sensitivities to PTH and normal responses to ACZ. Levels of vitamin D metabolites in the patients were normal. We conclude that patients with tumoral calcinosis have a reduced ability to excrete phosphorus. This defect does not seem to be due to impaired PTH secretion, an abnormal phosphaturic response to this hormone, or a disturbance of vitamin D metabolism.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D001774 Blood Chemical Analysis An examination of chemicals in the blood. Analysis, Blood Chemical,Chemical Analysis, Blood,Analyses, Blood Chemical,Blood Chemical Analyses,Chemical Analyses, Blood
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females

Related Publications

E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
January 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
June 2014, American journal of medical genetics. Part A,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
June 1987, The Quarterly journal of medicine,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
July 1988, The Journal of clinical endocrinology and metabolism,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
January 1977, Annals of internal medicine,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
April 1977, The Journal of pharmacology and experimental therapeutics,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
November 1972, Annals of internal medicine,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
February 1984, Revue du rhumatisme et des maladies osteo-articulaires,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
April 1995, Bone,
E G Lufkin, and D M Wilson, and L H Smith, and N J Bill, and H F DeLuca, and T P Dousa, and F G Knox
September 1978, Kidney international,
Copied contents to your clipboard!